Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Realizing the Full Value of Patient Centricity in Rare Disease: 5 Ways to Maximize Your Engagement Efforts By Kris O'Brien March 27, 2023 Clinical ResearchPhase 1 - Phase 4 At the Intersection of Rare Disease and Precision Medicine: A Road to Growth By Adam Bloomfield March 7, 2023 Clinical ResearchPhase 1 - Phase 4 Rare Disease Patients as Partners: Value Beyond Enrollment By Nicole Carswell March 6, 2023 Clinical ResearchPhase 1 - Phase 4 Charting the Path: How Patient and Caregiver Journeys Guide Rare Disease Study Design By Kris O'Brien February 15, 2023 Clinical ResearchPhase 1 - Phase 4 9 Tips for Designing and Operationalizing Early-Stage Precision Oncology Studies By Abie Ekangaki February 2, 2023 Clinical ResearchPhase 1 - Phase 4 Can Your Protocol Flex? The Importance of Adaptive Trial Designs in Precision Oncology Studies By Abie Ekangaki January 30, 2023 Previous 1 2 3 4 5 … 52 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today
